Mechanism and preclinical prevention of increased breast cancer risk caused by pregnancy

Author:

Haricharan Svasti12,Dong Jie2,Hein Sarah12,Reddy Jay P12,Du Zhijun2,Toneff Michael12,Holloway Kimberly2,Hilsenbeck Susan G2,Huang Shixia1,Atkinson Rachel3,Woodward Wendy4,Jindal Sonali56,Borges Virginia F56,Gutierrez Carolina2,Zhang Hong7,Schedin Pepper J568,Osborne C Kent2,Tweardy David J9,Li Yi12

Affiliation:

1. Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, United States

2. Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, United States

3. Department of Clinical Cancer Prevention, MD Anderson Cancer Center, Houston, United States

4. Division of Radiation Oncology, MD Anderson Cancer Center, Houston, United States

5. Division of Medical Oncology, University of Colorado Denver Anschutz Medical Campus, United States

6. Young Women’s Breast Cancer Translational Program, University of Colorado Denver Anschutz Medical Campus, Aurora, United States

7. Department of Pathology, MD Anderson Cancer Center, Houston, United States

8. Program in Cancer Biology, University of Colorado Denver Anschutz Medical Campus, Aurora, United States

9. Department of Medicine, Baylor College of Medicine, Houston, United States

Abstract

While a first pregnancy before age 22 lowers breast cancer risk, a pregnancy after age 35 significantly increases life-long breast cancer risk. Pregnancy causes several changes to the normal breast that raise barriers to transformation, but how pregnancy can also increase cancer risk remains unclear. We show in mice that pregnancy has different effects on the few early lesions that have already developed in the otherwise normal breast—it causes apoptosis evasion and accelerated progression to cancer. The apoptosis evasion is due to the normally tightly controlled STAT5 signaling going astray—these precancerous cells activate STAT5 in response to pregnancy/lactation hormones and maintain STAT5 activation even during involution, thus preventing the apoptosis normally initiated by oncoprotein and involution. Short-term anti-STAT5 treatment of lactation-completed mice bearing early lesions eliminates the increased risk after a pregnancy. This chemoprevention strategy has important implications for preventing increased human breast cancer risk caused by pregnancy.

Funder

Congressionally Directed Medical Research Programs

National Institutes of Health

Nancy Owens Memorial Foundation

Dan L Duncan Cancer Center

Lester and Sue Smith Breast Center

Specialized Programs of Research Excellence

Huffington Center

Cancer Prevention Research Institute of Texas

Robert and Janice McNair Foundation

Publisher

eLife Sciences Publications, Ltd

Subject

General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Cited by 46 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3